Spring naar content

Publications

All publications listed on this page are freely accessible under the Open Access policy. 

Reviews:

1: Masroor, A., Streefkerk, N., Van Grotel, M., et al., Local application of otoprotective compounds other than sodium thiosulfate to prevent cisplatin-induced hearing loss: a systematic review. Drug Delivery , 33(1), 2026. https://doi.org/10.1080/10717544.2026.2665892

2: Bracesco, L., Hendriks, D. & Artegiani, B., Fusion oncogenes in cancer: organoid models and novel therapeutic approaches. BMC Biology , 24, 135, 2026. https://doi.org/10.1186/s12915-026-02606-7

3: Streefkerk, N., Timmer, R., Larsson, AIE, et al., Prestin as a potential biomarker for cochlear injury: current evidence and future directions. European Archives of Oto-Rhino-Laryngology , 2026. https://doi.org/10.1007/s00405-026-10236-6

Articles:

1: Ding, M., Maspero, M., Harrabi, S., et al., Impact of deep learning on CT-based organ-at-risk delineation for flank irradiation in pediatric renal tumors: a SIOP-RTSG radiotherapy committee study. Clinical and Translational Radiation Oncology , 56, 2026, 101051. https://doi.org/10.1016/j.ctro.2025.101051

2: Klein Lebbink, WJ, De Koning, CC, Kunstek, H., et al., Identification of a Plasma Immune Marker Panel for Early Detection of Acute Graft-versus-Host Disease in Children. Blood Immunology & Cellular Therapy , 2026, 100035. https://doi.org/10.1016/j.bict.2026.100035

3: Vieira Martins, M., de Lorenzo, P., Kotecha, RS, et al., Sustained Benefit of Blinatumomab in Infants With KMT2A-Rearranged ALL: Long-Term Outcomes, Toxicity, and Pharmacokinetics. Journal of Clinical Oncology , 2026 Jan 8:JCO2501806. https://doi.org/10.1200/JCO-25-01806

4: Hanemaaijer, ES, Müskens, KF, Kal, IJ, et al., Single-cell multiomic atlas of healthy pediatric bone marrow reveals age-dependent differences in lineage differentiation driven by stromal signaling. Nature Immunology , 27, 613–623, 2026. https://doi.org/10.1038/s41590-026-02422-9

5: Tallon-Cobos, A.C., Vazaios, K., Waranecki, P., et al., CAR T cells targeting the glycoprotein GD2 show potent antitumor efficacy in high-risk ependymoma models. Journal of Clinical Investigation , 136(2), 2026, e193332. https://doi.org/10.1172/JCI193332

6: Yurddas, D., Nievelstein, RAJ, Bison, B., et al., Hypothalamic obesity following craniopharyngioma surgery: what is the role of hypothalamic T2 signal changes in brain MRI? Neuro-Oncology Advances , 8(1), January–December 2026, vdag050. https://doi.org/10.1093/noajnl/vdag050

7: Streefkerk, N., Geller, JI, Knight, K., et al., Avoiding Cisplatin-Related Hearing Loss, Including Implementing Sodium Thiosulfate as Otoprotectant Into Daily Pediatric Clinical Practice: Proceedings Based on Evidence and Expert Opinion From the Ototoxicity Taskforce of the SIOP Supportive Care Network. Ear and Hearing , 2026 Jun 26 (Epub ahead of print), PMID: 42370844. https://doi.org/10.1097/AUD.0000000000001856

8: Park, SWS, Sundquist, F., Teles, L., et al., Fraction-dependent dose dynamics and clinical safety in high-risk neuroblastoma treated with [177Lu]Lu-DOTATATE: results from the LuDO-N trial. European Journal of Nuclear Medicine and Molecular Imaging , 2026. https://doi.org/10.1007/s00259-026-07984-2

9: Beamish, J., Damiano, RM, Drijver, J., et al., The relationship between psychosocial risk and neurocognitive functioning early after childhood central nervous system tumor diagnosis. Journal of Neuropsychology , 2026, 1–18. https://doi.org/10.1111/jnp.70060

10: Hanemaaijer, ES, Müskens, KF, Kal, IJ  et al. Single-cell multiomic atlas of healthy pediatric bone marrow reveals age-dependent differences in lineage differentiation driven by stromal signaling.  Nat Immunol 27, 613–623 (2026). https://doi.org/10.1038/s41590-026-02422-9

11: Teles L, Tolboom N, Poot AJ, et al., Radioligand therapy for pediatric patients with solid tumors. Br J Radiol. 2026 Jul 7:tqag161. doi: 10.1093/bjr/tqag161. Epub ahead of print. PMID: 42412529.

12: Vieira Martins M, de Lorenzo P, Kotecha RS, et al., Immunoglobulin Depletion and Recovery Following Blinatumomab in Infants With KMT2A-Rearranged ALL. Pediatric Blood Cancer. 2026 Jul 24:e70547. doi: 10.1002/1545-5017.70547 . Epub ahead of print. PMID: 42496646.

Reviews:

1: Nienke Streefkerk, Amirhossein Masroor, James I. Geller et al. , Local application of sodium thiosulfate as an otoprotectant for cisplatin-exposed patients – A narrative literature review to explore the potential benefit for children with cancer, EJC Pediatric Oncology, Volume 5, 2025, 100211, https://doi.org/10.1016/j.ejcped.2024.100211 ( https://www.sciencedirect.com/science/article/pii/S2772610X24000710)

2: Jessica Beamish, Josephine Drijver, Marita Partanen,
Cognitive and adaptive functioning outcomes after cancer diagnosis in early childhood: A systematic review, EJC Pediatric Oncology,
Volume 5, 2025, 100237, https://doi.org/10.1016/j.ejcped.2025.100237. ( https://www.sciencedirect.com/science/article/pii/S2772610X2500025X )

Articles:

1: Mianyong Ding, Matteo Maspero, Annemieke S. Littooij, et al. , Deep learning-based auto-contouring of organs/structures-at-risk for pediatric upper abdominal radiotherapy, Radiotherapy and Oncology, 2025, 110914, https://doi.org/10.1016/j.radonc.2025.110914. https://www.sciencedirect.com/science/article/pii/S0167814025002099
 

2: Miguel Vieira Martins, Anna Sofie Buhl Rasmussen, Jesper Heldrup et al. , Therapeutic drug monitoring in the treatment of childhood acute lymphoblastic leukemia – a practical guideline, EJC Pediatric Oncology, 2025, 100225, https://doi.org/10.1016/j.ejcped.2025.100225  https://www.ejcped.com/article/S2772-610X%2825%2900012-1/fulltext .

3: Kunstek, H., Kieviet, J., Lindemans, C., et al.,Thymic peptides in immune reconstitution and clinical outcome after allogeneic hematopoietic cell transplantation. Blood Neoplasia , 2(2), 2025, 100090. https://doi.org/10.1016/j.bneo.2025.100090

4: Ferrao Blanco, MN, Kazybay, B., Belderbos, M., et al. , Distinct stromal cell populations define the B-cell acute lymphoblastic leukemia microenvironment.  Leukemia (2025). https://doi.org/10.1038/s41375-025-02734-z https://www.nature.com/articles/s41375-025-02734-z

5: Paeps, Marnik, Michele A.Scialla, Lamia P.Barakat, et al. , Implementing a Psychosocial Screener in Pediatric Oncology: Perspectives of Multidisciplinary Clinicians, Psycho-Oncology: e70356. https://doi.org/10.1002/pon.70356 .

 

1: Leonor Teles, Nelleke Tolboom, Sabine LA Plasschaert, et al.,  Potential of non-FDG PET radiotracers for pediatric patients with solid tumors, EJC Pediatric Oncology, Volume 4, 2024, 100203, ISSN 2772-610X, https://doi.org/10.1016/j.ejcped.2024.100203. (  https://www.sciencedirect.com/science/article/pii/S2772610X24000631  )